James A. Geraghty, Director at JUNIPER PHARMACEUTICALS INC (JNP), bought 2,000 shares at $4.82 ($10K) on 2017-03-17, disclosed to the SEC on 2017-03-20.
Open-market purchase of $10k JNP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| VYGR | BUY | 2018-08-21 | $110K | — | Filing → |
| IDRA | BUY | 2018-08-08 | $56K | — | Filing → |
| PIRS | BUY | 2018-05-16 | $58K | — | Filing → |